Ovarian cancer: Challenges of early detection

Nature Clinical Practice Oncology

Volumn 4, Issue 9, 2007, Pages 498-499

  Menon, Usha ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; CA 125 ANTIGEN;

CANCER INVASION; CANCER MORTALITY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FALSE POSITIVE RESULT; GENE MUTATION; GENETIC CODE; GENETIC RISK; GENETIC SCREENING; GYNECOLOGIC SURGERY; HIGH THROUGHPUT SCREENING; HUMAN; MUTATIONAL ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY CANCER; POSITRON EMISSION TOMOGRAPHY; POSTMENOPAUSE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SALPINGOOOPHORECTOMY; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; SURVIVAL TIME; TRANSVAGINAL ECHOGRAPHY;

BRCA1 PROTEIN; BRCA2 PROTEIN; FEMALE; GENETIC SCREENING; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; RANDOMIZED CONTROLLED TRIALS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 34548453660     PISSN: 17434254     EISSN: 17434262     Source Type: Journal    
DOI: 10.1038/ncponc0906     Document Type: Review

References (11)

1. Jacobs IJ et al. (1999) Screening for ovarian cancer: A pilot randomised controlled trial. Lancet 353: 1207-1210
2. DePriest PD and DeSimone CP (2003) Ultrasound sceening for the early detection of ovarian cancer. J Clin Oncol 21: 194-199
3. Scully RE (2000) Influence of origin of ovarian cancer on efficacy of screening. Lancet 355: 1028-1029
4. Hartge P et al. (2000) Complex ovarian cysts in postmenopausal women are not associated with ovarian cancer risk factors: Preliminary data from the plco cancer screening trial. Ann Epidemiol 10: 465
5. Crayford TJ et al. (2000) Benign ovarian cysts and ovarian cancer: a cohort study with implications for screening. Lancet 355: 1060-1063
6. Menon U et al. (2005) Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer. J Clin Oncol 23 7919-7926
7. Davies AP et al. (1993) The adnexal mass: Benign or malignant? Evaluation of a risk of malignancy index. Br J Obstet Gynaecol 100: 927-931
8. Buys SS et al. (2005) Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: Findings from the initial screen of a randomized trial. Am J Obstet Gynecol 193: 1630-1639
9. Menon U and Jacobs JI (2004) Tumour markers and screening. In Practical Gynecologic Oncology, vol 4, 43-66 (Ed Berek JS and Hacker NF) Philadelphia: Lippincott Williams & Wilkins
10. Skates SJ et al. (1999) Estimated duration of pre-clinical ovarian cancer from longitudinal CA125 levels [abstract]. Proc Am Assoc Cancer Res 43: 288
11. Jacobs I et al. (online 17 November 2006) UK Collaborative Trial of Ovarian Cancer Screening [www.ukctocs.org.uk] (accessed 8 June 2007)